Details of the Drug Formulations

General Information of Drug (ID: DMGA9X0)

Drug Name
Sodium nitroprusside Drug Info
Synonyms
Nitroprusside (Sodium); Sodium nitroprusside anhydrous; 14402-89-2; C5FeN6O.2Na; Nitropruss; Nitroprusid-natrium; Sodium nitroprussate; Nitroprussidnatrium [German]; C5FeN6O.2H2O.2Na; Sodium nitroprusside [USAN]; Na2[Fe(CN)5(NO)]; Sodium nitroprussiate dihydrate; Sodium nitrosylpentacyanoferrate; SCHEMBL3020702; CCRIS 1912; Sodium Nitroprusside (anhydrous); Disodium nitrosylpentacyanoferrate; Disodium pentacyanonitrosylferrate; CHEBI:29321; Nitroprussiate de sodium [French]; MolPort-003-926-312; disodium pentacyanidonitrosylfer
Indication
Disease Entry ICD 11 Status REF
Hypertension BA00-BA04 Approved [1]
Cross-matching ID
PubChem CID
11953895
ChEBI ID
CHEBI:9179
CAS Number
13755-38-9
TTD ID
D07XVR
ACDINA ID
D01432

Full List of Drug Formulations Containing This Drug

Sodium Nitroprusside 50mg/100ml solution
Company Formulation ID FDA Description
Exela Pharma F23288 Sodium Chloride
------------------------------------------------------------------------------------

References

1 Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications.Crit Care Res Pract.2012;2012:290805.